Press
TAG1 and PharmaLogic Announce Strategic Partnership to Advance Decentralized Lead-212 Generator Development
Collaboration accelerates TAG1’s Pb-212 generator development and supports PharmaLogic’s mission to scale radiopharmaceutical innovation. ST. LOUIS, June 24, 2025/PRNewswire/ – TAG1 Inc., a premier supplier
June 24, 2025
Former POINT Biopharma CEO, Joe McCann, Joins TAG1 Board to Advance Isotope Access in Radiopharmaceuticals
ST. LOUIS, Mo (May 20, 2025) — TAG1 Inc., a premier supplier of clinical quantities of medical isotopes, today announced the appointment of Joe McCann
May 19, 2025
TAG1 Inc. and NRG PALLAS Enter a Strategic Partnership to Expand Lead-212 Production
The multi-year partnership will boost the production of Radium-224, strengthening the supply of critical isotopes for Targeted Alpha Therapies (TATs). ST. LOUIS, Mo (Oct. 17,2024)– TAG1
October 15, 2024
